NCT02641912
- Conditions
- Mouth Diseases, Salivary Gland Diseases, Stomatognathic Diseases, +1 more
- Locations
-
- GSK Investigational Site Boston, Massachusetts, United States
Clinical trial condition
Xerostomia
Explore clinical trials studying Xerostomia. Study availability and eligibility vary by location and protocol.
107 public trials
8 recruiting studies
Xerostomia trial results
NCT02375451
- Conditions
- Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Neoplasms, +10 more
- Locations
-
- Boston Children's Hospital Boston, Massachusetts, United States
NCT02766127
- Conditions
- Dentin Sensitivity, Mouth Diseases, Salivary Gland Diseases, +3 more
- Locations
-
- Complex Operative Unit of Dentistry Sassari, Italy
NCT00426543
- Conditions
- Conjunctival Diseases, Conjunctivitis, Corneal Diseases, +15 more
- Locations
-
- Institute of Odontology, Faculty of Health Sciences, University of Copenhagen Copenhagen, Denmark
NCT02067572
- Conditions
- Mouth Diseases, Oral Ulcer, Salivary Gland Diseases, +3 more
- Locations
-
- Lovisenberg Hospice Oslo, Norway
NCT02687087
- Conditions
- Mouth Diseases, Salivary Gland Diseases, Stomatognathic Diseases, +1 more
- Locations
-
- Beatson West of Scotland Cancer Centre Glasgow, Lanarkshire, United Kingdom
Completed
Randomized Amifostine For SCCHN
NCT00095927
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Chemotherapeutic Agent Toxicity, +18 more
- Locations
-
- Goodall Hospital Sanford, Maine, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
NCT02587676
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Disease, +9 more
- Locations
-
Not specified
NCT02854358
- Conditions
- Head and Neck Cancers, Head and Neck Neoplasms, Mouth Diseases, +5 more
- Locations
-
Not specified
Completed
Drug-induced Xerostomia. Evaluation of Malic Acid 1%, Salivary Mucins and Buffering Capacity
NCT01652001
- Conditions
- Behavior, Behavioral Symptoms, Cardiovascular Diseases, +7 more
- Locations
-
- Dental School Granada, Spain